Boai NKY Medical Holdings Ltd operates in the Industrial organic chemicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boai NKY Medical Holdings Ltd with three other
companies in this sector in China:
Shandong Sinobioway Biomedicine Co Ltd
sales of 664.59 million Chinese Renmimbi [US$94.97 million]
of which 95%
JiangXi ChangJiu Biochemical Industry Company Limited
(528.48 million Chinese Renmimbi [US$75.52 million]
of which 86%
was Industry), and
Changmao Biochemical Engineering Co Ltd
(639.12 million Chinese Renmimbi [US$91.33 million]
Boai NKY Medical Holdings Ltd reported sales of 698.28 million Chinese Renmimbi (US$99.78 million)
December of 2018.
increase of 42.9%
versus 2017, when the company's sales were 488.58 million Chinese Renmimbi.
Sales at Boai NKY Medical Holdings Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 234%).